Liquid Biopsy Identifies Advanced Lung Cancer Drivers
Liquid biopsy for plasma circulating tumor DNA (ctDNA) next-generation sequencing (NGS) is commercially available and increasingly adopted in clinical practice despite a paucity of prospective data to support its use.
Product Showcase
ELISA Processor
The AP22 IF BLOT ELITE can run two ELISA microplates with eight tests online, 16 IFA slides or 24 western blot or LIA... Read more...
Latest News
- Diabetic Retinopathy Linked to Glycemic Variability in Type 2-Diabetes
- Plasmodium vivax Isolated in Duffy Negative Individuals
- MALDI-TOF MS Identifies Oomycete Causing Pythiosis
- Inexpensive Biosensor Provides Rapid Diagnosis of Bacterial Infections
- Transfusions with Older Blood Linked to Adverse Events
- Circulating Tumor DNA Detects Early Melanoma Growth
- Strongyloidiasis Antibodies Found in Transplant Donors
- Potential Biomarkers Found for Acute Aortic Dissection
